GPC
40
3
VNO
60
10
COF
60
2
FDX
43
3
IBM
58
-2
MAT
46
12
HON
67
2
YUM
47
3
NKE
36
6
SLB
55
2
MA
64
7
UPS
60
9
FE
50
-2
STZ
54
-3
VTR
47
-7
IPG
56
3
HPQ
63
6
BWA
48
2
R
71
4
EOG
58
2
GPC
40
3
VNO
60
10
COF
60
2
FDX
43
3
IBM
58
-2
MAT
46
12
HON
67
2
YUM
47
3
NKE
36
6
SLB
55
2
MA
64
7
UPS
60
9
FE
50
-2
STZ
54
-3
VTR
47
-7
IPG
56
3
HPQ
63
6
BWA
48
2
R
71
4
EOG
58
2
Financhill
Back

abrdn Life Sciences Investors Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24

HQL
abrdn Life Sciences Investors

Last Price:
13.78
Seasonality Move:
10.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

abrdn Life Sciences Investors Stock Forecast

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 3.6% based on the past 26 years of stock performance.
  • abrdn Life Sciences Investors has risen higher in 15 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.69%
  • Is abrdn Life Sciences Investors Stock Undervalued?
    The current abrdn Life Sciences Investors [HQL] share price is $13.79. The Score for HQL is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • HQL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will abrdn Life Sciences Investors Stock Go Up Next Year?

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 3.6% based on the past 26 years of stock performance.

abrdn Life Sciences Investors Stock Rating

Sell
24
abrdn Life Sciences Investors (HQL) is a Sell

Is abrdn Life Sciences Investors overpriced?

  • abrdn Life Sciences Investors has risen higher in 15 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.69%

abrdn Life Sciences Investors Stock Price History

Is HQL stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HQL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Sector:
Type:
stock
Website:
abrdnhql.com

52-Week Data

52-Week High:
15.90
52-Week Low:
11.62

Prediction Charts

Market Cap:
0
Price in USD:
13.79
Volume:
116.7K
Beta:
0.96

Technical Analysis

SMA50:
14.91
SMA100:
15.03
SMA200:
14.33
52-Wk Change:
17.06%

Stock Predictions

  • Is abrdn Life Sciences Investors stock public?
    Yes, abrdn Life Sciences Investors is a publicly traded company.
  • What is the abrdn Life Sciences Investors stock quote today?
    The abrdn Life Sciences Investors stock price is 13.79 USD today.
  • How to buy abrdn Life Sciences Investors stock online?
    You can buy abrdn Life Sciences Investors shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 14.78 14.93 14.95 14.72
Nov-6 15.20 14.97 15.20 14.95
Nov-7 15.09 15.18 15.24 15.09
Nov-8 15.20 15.22 15.24 15.06
Nov-11 15.25 15.25 15.37 15.25
Nov-12 15.25 15.02 15.28 14.97
Nov-13 15.08 14.74 15.10 14.71
Nov-14 14.72 14.43 14.76 14.39
Nov-15 14.38 13.72 14.38 13.70
Nov-18 13.86 14.17 14.17 13.76
Nov-19 14.13 14.21 14.23 14.01
Nov-20 14.24 14.30 14.37 14.24
Nov-21 13.80 13.83 13.88 13.68
Nov-22 13.83 13.79 13.90 13.72

abrdn Life Sciences Investors Earnings

Data Unavailable

abrdn Life Sciences Investors Forecast Revenue Growth

Data Unavailable

* abrdn Life Sciences Investors stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.